A research team at the University of Washington has harnessed complex computational methods to design customized proteins that can self-assemble into 120-subunit “icosahedral” structures inside living cells—the biggest, self-booting, intracellular protein nanocages ever made. The breakthrough offers a potential solution to a pressing scientific challenge: how to safely and efficiently deliver to cells new and emerging biomedical treatments such as DNA vaccines and therapeutic interfering particles.
The work, funded by DARPA in a lead-up to the new INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program, “opens the door to a new generation of genetically programmable protein-based molecular machines,” the researchers report in this week’s issue of the journal Science. The research paper is available here: http://ow.ly/LW8F302tOp3
Anyone familiar with the role-playing games Dungeons and Dragons and Munchkin need only picture the 20-sided die to understand what an organic, icosahedral cargo container looks like—symmetrical, triangle-shaped panels folded evenly on each side. Unlike a die that can be held in your hand, however, these creations are the size of small viruses and are designed to interact with cells in the same way viruses might—that is, by delivering their caged contents into a cell, albeit in this case with positive, customizable outcomes. Also, whereas dice are produced in molds on a factory assembly line, these nanocages build themselves inside cells, following with atomic precision instructions written in genetic code.
Nature provides many examples of self- and co-assembling protein-based molecular structures like icosahedral protein cages. They serve as scaffolds, enzymes, and compartments for biochemical reactions in the body, and they form virus capsids—the geodesic-like protein enclosures that protect viral genomes from the human body’s immune system and facilitate their entry into cells.
“Viruses offer researchers many lessons on ways to access the body and use the body’s resources for their own purposes. DARPA is studying how to apply those tricks to the challenge of overcoming infectious disease,” said Jim Gimlett, the DARPA program manager overseeing the University of Washington effort and the INTERCEPT program. Among other goals, that program seeks to deliver into cells protein snippets that can co-evolve with viruses and provide ongoing immune protection even as viruses mutate and change.
Viruses consist of two main parts: genetic material (DNA or RNA) surrounded by a protein shell. To reproduce, a virus first attaches itself to a cell within a host organism. This occurs when a virion protein on the virus binds to a complementary molecule on the surface of the cell. The virus then enters the cell and releases its genetic material inside. These viral genes hijack the cell’s biological machinery, forcing the cell to generate new copies of the viral genome and shell proteins. While still inside the host cell, those freshly minted viral genomes and protein shells assemble into new viruses, which eventually burst from the cell and disperse to infect others.
DARPA’s focus is on the protein shells. If scientists could design customized shells and program them to embrace specific payloads and replicate within the body, they could open new pathways for personalized medicines and therapies. However, the universe of proteins is large, and the combinations of ways in which those proteins can—based on electromagnetic charges and other factors—link to one another and spontaneously fold within three-dimensional space is devilishly complex.
When designing a protein assembly process, the nature of the selected proteins and how they fold will determine if that creation can bind to particular cell receptors and whether it can accommodate a desired cargo such as small molecules, antibodies, nucleic acids, polymers, or other proteins. “Protein folding can be compared to a 3-D puzzle with thousands of pieces and an astronomical number of possible solutions, but only one of those solutions might be right for a particular need,” Gimlett said.
The University of Washington’s latest research used combinatorial computations to consider hundreds of thousands of possible protein combinations and then characterize in detail a few hundred of those designs. Then the team inserted genes encoding the desired protein sequences into E. coli bacteria to test how the instructions would be carried out within living cells. Ten of the designs resulted in assemblies within those bacteria similar to the intended three-dimensional configurations. In fact, tests conducted using small-angle X-ray scattering and negative-stain electron microscopy revealed that these cage-like structures had self-assembled with near-perfect, atomic-scale precision.
Icosahedra possess the highest possible symmetry of any polyhedron in three-dimensional space, and thus generate the maximum enclosed volume for packaging cargo among symmetric assemblies of polymers. The accurate self-assembly of a 120-subunit icosahedral protein cage is a five-fold improvement over what had been, until recently, the previous record for such a structure: a 24-subunit, two-component tetrahedron. Just last month, the Seattle team announced that it had broken that record by designing a hyperstable, self-assembling 60-subunit icosahedron, research that was featured in the journal Nature. In their latest paper, the researchers note that the 120-subunit assembly either hasn’t evolved in nature or has yet to be discovered.
“This construct’s generous capacity, and the accuracy with which it builds itself, bode well for the field of biomolecular engineering,” Gimlett said. “I look forward to seeing some of the innovative applications that will surely emerge with the arrival of this robust new platform.”
Image caption: Characterization of the designed protein cages using electron
microscopy. All of the raw micrographs are shown to scale relative to the
30-nanometer scale bar in panel H. (Image: University of Washington via
You are now leaving the DARPA.mil website that is under the control and
management of DARPA. The appearance of hyperlinks does not constitute
endorsement by DARPA of non-U.S. Government sites or the information,
products, or services contained therein. Although DARPA may or may not
use these sites as additional distribution channels for Department of
Defense information, it does not exercise editorial control over all of
the information that you may find at these locations. Such links are
provided consistent with the stated purpose of this website.
After reading this message, click to continue